A randomized controlled study on perioperative treatment of esophageal squamous cell carcinoma with camrelizumab combined with nab-paclitaxel and cisplatin

被引：0
|
作者：
Qi, Yu
Yang, Yang
Li, Weihao
Yue, Songwei
Ma, Yihui
Liu, Donglei
He, Zhanfeng
Chen, Lidong
Li, Wencai
Li, Linghua
Zhao, Song
机构：
[1] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Zhengzhou, Peoples R China
[3] Jiangsu Hengrui Med Co Ltd, Lianyungang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16075
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort study
    Yu, Nuo
    Chen, Xiankai
    Li, Jiao
    Kang, Xiaozheng
    Wang, Zhen
    Zhang, Ruixiang
    Qin, Jianjun
    Li, Yong
    Zheng, Qingfeng
    Feng, Guojie
    Deng, Lei
    Zhang, Tao
    Wang, Wenqing
    Liu, Wenyang
    Wang, Jianyang
    Feng, Qinfu
    Lv, Jima
    Zhou, Zongmei
    Xiao, Zefen
    Bi, Nan
    Li, Yin
    Wang, Xin
    STRAHLENTHERAPIE UND ONKOLOGIE, 2024, 200 (12) : 1038 - 1046
  • [22] Weekly nab-paclitaxel in combination with cisplatin as neoadjuvant chemotherapy in patients (pts) with locally advanced esophageal squamous cell carcinoma (SCC): Preliminary results of a phase study.
    Jiang, Youhua
    Yun, Fan
    Chen, Qixun
    Zhou, Xinming
    Huang, Zhiyu
    Gong, Lei
    Yang, Haiyan
    Yu, Haifeng
    Liu, Jinshi
    Chen, Pengcheng
    Zhao, Qiang
    Mao, Weimin
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] Tislelizumab combined with nab-paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two-cohort, phase 2 trial
    Wang, Jie
    Li, Bin
    Zhang, Yawei
    Luo, Xiaoyang
    Zhang, Yiliang
    Li, Hang
    Pan, Yunjian
    Shao, Longlong
    Zheng, Shanbo
    Yuan, Chongze
    Li, Yuan
    Zheng, Qiang
    Sun, Si
    Zhao, Weixin
    Sun, Yihua
    INTERNATIONAL JOURNAL OF CANCER, 2025, 156 (07) : 1429 - 1438
  • [24] nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial
    Peter Oppelt
    Jessica Ley
    Mackenzie Daly
    Jason Rich
    Randal Paniello
    Ryan S. Jackson
    Patrik Pipkorn
    Jingxia Liu
    Hiram Gay
    Kevin Palka
    Prakash Neupane
    Steven Powell
    William C. Spanos
    Mark Gitau
    Jose Zevallos
    Wade Thorstad
    Douglas Adkins
    Medical Oncology, 2021, 38
  • [25] nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial
    Oppelt, Peter
    Ley, Jessica
    Daly, Mackenzie
    Rich, Jason
    Paniello, Randal
    Jackson, Ryan S.
    Pipkorn, Patrik
    Liu, Jingxia
    Gay, Hiram
    Palka, Kevin
    Neupane, Prakash
    Powell, Steven
    Spanos, William C.
    Gitau, Mark
    Zevallos, Jose
    Thorstad, Wade
    Adkins, Douglas
    MEDICAL ONCOLOGY, 2021, 38 (04)
  • [26] Apatinib Combined with Paclitaxel and Cisplatin Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
    Zhao, Jidong
    He, Ming
    Li, Jie
    Li, Dan
    Zhao, Yang
    Li, Xinhui
    Zhang, Xiangmei
    Chen, Xin
    Liu, Yunjiang
    Zhao, Liyan
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (04) : 324 - 331
  • [27] Survival outcomes in patients with locally advanced esophageal squamouscell carcinoma treated with nab-paclitaxel and cisplatin as neoadjuvant chemotherapy
    Yun, F.
    Jiang-, Y.
    Chen, Q.
    Zhou, X.
    Huang, Z.
    Mao, W.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S411 - S412
  • [28] Neoadjuvant pembrolizumab/nab-paclitaxel/cisplatin in patients with locally advanced head and neck squamous cell carcinoma: A single-arm phase II study
    Zhang, Siyi
    Ma, Haiqing
    Zhan, Jiandong
    Zhu, Lijun
    Zhang, Hong-Dan
    Du, Shasha
    Dong, Qiumei
    Wang, Guangyi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma
    Shi, Yan
    Qin, Rui
    Wang, Zhi-Kuan
    Dai, Guang-Hai
    ONCOTARGETS AND THERAPY, 2013, 6 : 585 - 591
  • [30] Neoadjuvant PD-1 inhibitor combined with Nab-paclitaxel and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NCT05522985): A randomized, controlled, open label, phase II clinical trial
    Wang, H.
    Wang, X.
    Zhou, X.
    Li, Y.
    Wang, P.
    Zhang, X.
    Pan, Y.
    Cheng, R.
    Xiao, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S571 - S572
12345